Yuji Sato

JCR Pharmaceuticals (Japan) — Japan

Medicine · Health Sciences

15h-index826citations78works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lysosomal Storage Disorders Research(25), Glycogen Storage Diseases and Myoclonus(16), Monoclonal and Polyclonal Antibodies Research(7), HER2/EGFR in Cancer Research(6), Human Pose and Action Recognition(6)

Publications78 total

Infusion rate adjustment in enzyme replacement therapy with pabinafusp alfa for mucopolysaccharidosis II
2025Open Access
Bidirectional Action Sequence Learning for Long-term Action Anticipation with Large Language Models
arXiv (Cornell University)·2025Open Access
Bidirectional Action Sequence Learning for Long-term Action Anticipation with Large Language Models
2025
Resolution of extensive Mongolian spots (dermal melanocytosis) in a patient with mucopolysaccharidosis type II undergoing enzyme replacement therapy with pabinafusp alfa: A case report
Brain and Development Case Reports·2025Open Access
Long-term impact of pabinafusp alfa on disease burden in Hunter syndrome: A 4-year follow-up of patient-reported outcomes
Molecular Genetics and Metabolism·2025
Analysis of caregiver perspectives on patients with mucopolysaccharidosis II treated with pabinafusp alfa: results of qualitative interviews in Japan
Orphanet Journal of Rare Diseases·2024· 3 citedOpen Access
Corrigendum to “On emerging enzyme replacement therapies for neuronopathic mucopolysaccharidosis II” [Molecular Genetics and Metabolism Volume 141, Issue 3 (2024) 108143]
Molecular Genetics and Metabolism·2024
A global phase III study of pabinafusp alfa (JR-141) for neuronopathic mucopolysaccharidosis type II: Updated study design
Molecular Genetics and Metabolism·2024
Integrated long-term efficacy and safety data on enzyme replacement therapy with pabinafusp alfa for neuronopathic mucopolysaccharidosis type II (MPS II): Updated clinical data from Japan and Brazil
Molecular Genetics and Metabolism·2024
A phase I/II clinical trial of JR-441 for treatment of Sanfilippo syndrome type A (MPS IIIA)
Molecular Genetics and Metabolism·2024
Efficacy and safety data (52-week) from a phase 1/2 trial and extension study of JR-171 (lepunafusp alfa) used in enzyme replacement therapy for patients with MPS I
Molecular Genetics and Metabolism·2024
On emerging enzyme replacement therapies for neuronopathic mucopolysaccharidosis II
Molecular Genetics and Metabolism·2024
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial
Molecular Therapy·2024· 13 citedOpen Access
Efficacy and safety of GH treatment in Japanese children with short stature due to <i>SHOX</i> deficiency: a randomized phase 3 study
Clinical Pediatric Endocrinology·2024· 1 citedOpen Access
Inverse-problem Approach to Dispersion Properties of 2D Phononic Crystals using Deep Learning and NSGA-II
Keisan Rikigaku Koenkai koen ronbunshu/Keisan Rikigaku Kouenkai kouen rombunshuu·2024Open Access
Caregiver Perspectives on Patients with Mucopolysaccharidosis II Treated with Pabinafusp Alfa: Results of Qualitative Interviews in Japan
2023Open Access
Inverse Problem Approach to Dispersion Analysis of Phononic Crystals Using Multilayer Neural Networks
Keisan Rikigaku Koenkai koen ronbunshu/Keisan Rikigaku Kouenkai kouen rombunshuu·2023Open Access
Treatment of CLN1 disease with a blood-brain barrier penetrating lysosomal enzyme
Molecular Genetics and Metabolism Reports·2022· 5 citedOpen Access
Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study
Growth Hormone & IGF Research·2022· 2 citedOpen Access
Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
Pharmaceutics·2022· 25 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Kazunori Tanizawa(15), Tatsuyoshi Yamamoto(14), Sairei So(12), Hiroyuki Sonoda(11), Mathias Schmidt(11), Toshiaki Ikeda(10), Norio Sakai(8), Kimitoshi Nakamura(7), Kohtaro Minami(7), Yasuyoshi Yokokohji(6), Torayuki Okuyama(5), Yoshikatsu Eto(5), Mariko Yamaoka(5), Roberto Giugliani(5), Ana Maria Martins(4), Nobuhiko Muramori(4), Yoshimitsu Aoki(4), Tohru Hirato(3), Takashi Hamazaki(3), Naoko Takasao(3)